EDGE THERAPEUTICS (EDGE) analyst actions
Rating and price-target actions on EDGE in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the EDGE overview →
No EDGE analyst action events in the measured window.
Nothing matched in the current window — the EDGE overview has every event we measure for this name.
Get an email when EDGE moves on news →Keep exploring
More EDGE: earnings → · SEC filings → · EDGE overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AKCEA THERAPEUTICS (AKCA) | 401 | 0.00% | 49% |
| Blueprint Medicines Corporation (BPMC) | 401 | -0.03% | 46% |
| Esperion Therapeutics, Inc. (ESPR) | 401 | 0.00% | 47% |
| Novavax, Inc. (NVAX) | 400 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.